Teacher Retirement System of Texas Has $217,000 Holdings in Harrow, Inc. (NASDAQ:HROW)

Teacher Retirement System of Texas trimmed its stake in shares of Harrow, Inc. (NASDAQ:HROW) by 9.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,146 shares of the company’s stock after selling 805 shares during the period. Teacher Retirement System of Texas’ holdings in Harrow were worth $217,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in HROW. Woodmont Investment Counsel LLC raised its position in Harrow by 0.5% during the fourth quarter. Woodmont Investment Counsel LLC now owns 81,400 shares of the company’s stock worth $2,731,000 after acquiring an additional 445 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Harrow by 3.5% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,356 shares of the company’s stock worth $582,000 after acquiring an additional 585 shares in the last quarter. Swiss National Bank raised its position in shares of Harrow by 1.0% in the fourth quarter. Swiss National Bank now owns 59,300 shares of the company’s stock valued at $1,990,000 after purchasing an additional 600 shares during the period. GF Fund Management CO. LTD. bought a new position in shares of Harrow in the fourth quarter valued at about $25,000. Finally, MetLife Investment Management LLC lifted its stake in shares of Harrow by 5.7% during the 4th quarter. MetLife Investment Management LLC now owns 18,908 shares of the company’s stock worth $634,000 after buying an additional 1,026 shares during the last quarter. 72.76% of the stock is currently owned by institutional investors and hedge funds.

Harrow Price Performance

NASDAQ HROW opened at $35.89 on Friday. Harrow, Inc. has a one year low of $20.85 and a one year high of $59.23. The stock has a 50-day moving average of $30.13 and a 200 day moving average of $28.84. The company has a market capitalization of $1.32 billion, a price-to-earnings ratio of -64.09 and a beta of 0.41. The company has a debt-to-equity ratio of 2.01, a quick ratio of 0.85 and a current ratio of 0.91.

Harrow (NASDAQ:HROW) last released its earnings results on Thursday, May 8th. The company reported ($0.38) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.40). Harrow had a negative net margin of 10.19% and a negative return on equity of 25.01%. The company had revenue of $47.83 million for the quarter, compared to the consensus estimate of $57.00 million. On average, sell-side analysts forecast that Harrow, Inc. will post -0.53 EPS for the current year.

Analyst Ratings Changes

Several analysts have weighed in on the stock. HC Wainwright lifted their price objective on shares of Harrow from $57.00 to $60.00 and gave the stock a “buy” rating in a research note on Monday, May 12th. Cantor Fitzgerald started coverage on shares of Harrow in a research report on Friday, July 11th. They set an “overweight” rating and a $76.00 target price on the stock. William Blair started coverage on shares of Harrow in a report on Tuesday, June 10th. They set an “outperform” rating for the company. B. Riley lowered their price target on shares of Harrow from $69.00 to $65.00 and set a “buy” rating for the company in a report on Tuesday, April 1st. Finally, BTIG Research began coverage on shares of Harrow in a research note on Thursday, June 12th. They issued a “buy” rating and a $62.00 price objective for the company. Seven investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $63.83.

Harrow Company Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.